Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A

Biochimie

Volumn 104, Issue 1, 2014, Pages 70-80

  Aguilera, J Javier ^a   Zhang, Fuming ^b,c   Beaudet, Julie M ^a   Linhardt, Robert J ^a,b,c   Colón, Wilfredo ^a,c  

^a Research Rensselaer Polytechnic Institute   (United States)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^c RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Fibrillation kinetics; GAGs; Inflammation; Reactive amyloidosis

Indexed keywords

CHONDROITIN 4 SULFATE; GLYCOSAMINOGLYCAN POLYSULFATE; HEPARAN SULFATE; HEPARIN; HIGH DENSITY LIPOPROTEIN; HYALURONIC ACID; SERUM AMYLOID A; GLYCOSAMINOGLYCAN; SAA2 PROTEIN, MOUSE;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OLIGOMERIZATION; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN INTERACTION; SULFATION; SURFACE PLASMON RESONANCE; AMINO ACID SEQUENCE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; KINETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN MULTIMERIZATION; PROTEIN REFOLDING; PROTEIN SECONDARY STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; GLYCOSAMINOGLYCANS; HEPARIN; KINETICS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN MULTIMERIZATION; PROTEIN REFOLDING; PROTEIN STRUCTURE, SECONDARY; SERUM AMYLOID A PROTEIN;

EID: 84905459592     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2014.05.007     Document Type: Article

References (61)

1. J.D. Sipe Amyloidosis Annu. Rev. Biochem. 61 1992 947 975
2. D.R. van der Westhuyzen, F.C. de Beer, and N.R. Webb HDL cholesterol transport during inflammation Curr. Opin. Lipidol. 18 2007 147 151
3. K.K. Eklund, K. Niemi, and P.T. Kovanen Immune functions of serum amyloid A Crit. Rev. Immunol. 32 2012 335 348
4. M.K. Ganapathi, D. Rzewnicki, D. Samols, S.L. Jiang, and I. Kushner Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells J. Immunol. 147 1991 1261 1265
5. E. Tatsuta, J.D. Sipe, T. Shirahama, M. Skinner, and A.S. Cohen Different regulatory mechanisms for serum amyloid A and serum amyloid P synthesis by cultured mouse hepatocytes J. Biol. Chem. 258 1983 5414 5418
6. K.P. McAdam, and J.D. Sipe Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein J. Exp. Med. 144 1976 1121 1127
7. G. Hass Studies of amyloid. II. The isolation of a polysaccharide from amyloid-bearing tissues Arch. Pathol. 34 1942 92 105
8. I. Capila, and R.J. Linhardt Heparin-protein interactions Angew. Chem. Int. Ed. Engl. 41 2002 391 412
9. N.S. Gandhi, and R.L. Mancera The structure of glycosaminoglycans and their interactions with proteins Chem. Biol. Drug Des. 72 2008 455 482
10. M. Roth, E. Papakonstantinou, and G. Karakiulakis Biological function of glycosaminoglycans M.K.C.H.G. Garg, C.A. Hales, Carbohydrate Chemistry, Biology and Medical Applications 2008 Elsevier 209 226
11. C. Rokitansky Handbuch der Speciellen Pathologischen Anatomica 1842 Braumuller und Seidel Vienna 311 312
12. R.A. Kyle Amyloidosis: a convoluted story Br. J. Haematol. 114 2001 529 538
13. N. Friedreich, and A. Kekulé Zur Amyloidfrage Arch. Pathol. Anat. Physiol. Klin. Med. 16 1859 50 65
14. T. Ariga, T. Miyatake, and R.K. Yu Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: amyloidogenesis and therapeutic strategies - a review J. Neurosci. Res. 88 2010 2303 2315
15. N. Motamedi-Shad, E. Monsellier, and F. Chiti Amyloid formation by the model protein muscle acylphosphatase is accelerated by heparin and heparan sulphate through a scaffolding-based mechanism J. Biochem. 146 2009 805 814
16. D.J. Martin, and M. Ramirez-Alvarado Glycosaminoglycans promote fibril formation by amyloidogenic immunoglobulin light chains through a transient interaction Biophys. Chem. 158 2011 81 89
17. T. Bitter, and H. Muir Mucopolysaccharides of whole human spleens in generalized amyloidosis J. Clin. Invest. 45 1966 963 975
18. T. Okuyama, and K.I. Turumi Acid mucopolysaccharide from a spleen of primary amyloidosis Clin. Chim. Acta 8 1963 140 142
19. A.W. Lyon, S. Narindrasorasak, I.D. Young, T. Anastassiades, J.R. Couchman, K.J. McCarthy, and R. Kisilevsky Co-deposition of basement membrane components during the induction of murine splenic AA amyloid Lab. Invest. 64 1991 785 790
20. A.D. Snow, J. Willmer, and R. Kisilevsky Sulfated glycosaminoglycans: a common constituent of all amyloids? Lab. Invest. 56 1987 120 123
21. A. Linker, P. Hoffman, P. Sampson, and K. Meyer Heparitin sulfate Biochim. Biophys. Acta 29 1958 443 444
22. J.B. Ancsin, and R. Kisilevsky The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis J. Biol. Chem. 274 1999 7172 7181
23. S.R. Nelson, M. Lyon, J.T. Gallagher, E.A. Johnson, and M.B. Pepys Isolation and characterization of the integral glycosaminoglycan constituents of human amyloid A and monoclonal light-chain amyloid fibrils Biochem. J. 275 Pt 1 1991 67 73
24. A. Linker, and H.C. Carney Presence and role of glycosaminoglycans in amyloidosis Lab. Invest. 57 1987 297 305
25. L. Obici, S. Raimondi, F. Lavatelli, V. Bellotti, and G. Merlini Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview Arthritis Rheum. 61 2009 1435 1440
26. E. Elimova, R. Kisilevsky, W.A. Szarek, and J.B. Ancsin Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy FASEB J. 18 2004 1749 1751
27. J.P. Li, M.L. Galvis, F. Gong, X. Zhang, E. Zcharia, S. Metzger, I. Vlodavsky, R. Kisilevsky, and U. Lindahl In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis Proc. Natl. Acad. Sci. U. S. A. 102 2005 6473 6477
28. E. Elimova, R. Kisilevsky, and J.B. Ancsin Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch FASEB J. 23 2009 3436 3448
29. F. Noborn, J.B. Ancsin, W. Ubhayasekera, R. Kisilevsky, and J.P. Li Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation J. Biol. Chem. 287 2012 25669 25677
30. R. Kisilevsky, J.B. Ancsin, W.A. Szarek, and S. Petanceska Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications Amyloid 14 2007 21 32
31. R. Kisilevsky, L.J. Lemieux, P.E. Fraser, X. Kong, P.G. Hultin, and W.A. Szarek Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease Nat. Med. 1 1995 143 148
32. R. Kisilevsky, W.A. Szarek, J.B. Ancsin, E. Elimova, S. Marone, S. Bhat, and A. Berkin Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy-alpha- and beta-d-glucose: implications for the treatment of various amyloidoses Am. J. Pathol. 164 2004 2127 2137
33. L.M. Dember, P.N. Hawkins, B.P. Hazenberg, P.D. Gorevic, G. Merlini, I. Butrimiene, A. Livneh, O. Lesnyak, X. Puechal, H.J. Lachmann, L. Obici, R. Balshaw, D. Garceau, W. Hauck, M. Skinner A.A.A.T.G Eprodisate for, eprodisate for the treatment of renal disease in AA amyloidosis N. Engl. J. Med. 356 2007 2349 2360
34. S.K. Lee, K.E. Lee, Y.H. Hwang, M. Kida, T. Tsutsumi, T. Ariga, J.C. Park, and J.W. Kim Identification of the DSPP mutation in a new kindred and phenotype-genotype correlation Oral Dis. 17 2011 314 319
35. S. Srinivasan, S. Patke, Y. Wang, Z. Ye, J. Litt, S.K. Srivastava, M.M. Lopez, D. Kurouski, I.K. Lednev, R.S. Kane, and W. Colon Pathogenic serum amyloid a 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2 J. Biol. Chem. 288 2013 2744 2755
36. H. Naiki, K. Higuchi, M. Hosokawa, and T. Takeda Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1 Anal. Biochem. 177 1989 244 249
37. M.R. Krebs, E.H. Bromley, and A.M. Donald The binding of thioflavin-T to amyloid fibrils: localisation and implications J. Struct. Biol. 149 2005 30 37
38. E. Bazar, and R. Jelinek Divergent heparin-induced fibrillation pathways of a prion amyloidogenic determinant Chembiochem 11 2010 1997 2002
39. G. Ramachandran, and J.B. Udgaonkar Understanding the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by Tau protein J. Biol. Chem. 286 2011 38948 38959
40. R. Kayed, E. Head, F. Sarsoza, T. Saing, C.W. Cotman, M. Necula, L. Margol, J. Wu, L. Breydo, J.L. Thompson, S. Rasool, T. Gurlo, P. Butler, and C.G. Glabe Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers Mol. Neurodegener. 2 2007 18
41. C.G. Glabe Structural classification of toxic amyloid oligomers J. Biol. Chem. 283 2008 29639 29643
42. G.M. Castillo, W. Lukito, T.N. Wight, and A.D. Snow The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation J. Neurochem. 72 1999 1681 1687
43. R. Ren, Z. Hong, H. Gong, K. Laporte, M. Skinner, D.C. Seldin, C.E. Costello, L.H. Connors, and V. Trinkaus-Randall Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils J. Biol. Chem. 285 2010 37672 37682
44. S. Bourgault, J.P. Solomon, N. Reixach, and J.W. Kelly Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion Biochemistry 50 2011 1001 1015
45. R. Gupta, N. Kapoor, D.P. Raleigh, and T.P. Sakmar Nucleobindin 1 caps human islet amyloid polypeptide protofibrils to prevent amyloid fibril formation J. Mol. Biol. 421 2012 378 389
46. J.Y. Suk, F. Zhang, W.E. Balch, R.J. Linhardt, and J.W. Kelly Heparin accelerates gelsolin amyloidogenesis Biochemistry 45 2006 2234 2242
47. S.A. Sievers, J. Karanicolas, H.W. Chang, A. Zhao, L. Jiang, O. Zirafi, J.T. Stevens, J. Munch, D. Baker, and D. Eisenberg Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation Nature 475 2011 96 100
48. R.W. McLaughlin, J.K. De Stigter, L.A. Sikkink, E.M. Baden, and M. Ramirez-Alvarado The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein Protein Sci. 15 2006 1710 1722
49. A.J. Borysik, I.J. Morten, S.E. Radford, and E.W. Hewitt Specific glycosaminoglycans promote unseeded amyloid formation from beta2-microglobulin under physiological conditions Kidney Int. 72 2007 174 181
50. L. Wang, H.A. Lashuel, T. Walz, and W. Colon Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel Proc. Natl. Acad. Sci. U. S. A. 99 2002 15947 15952
51. L. Wang, and W. Colon Urea-induced denaturation of apolipoprotein serum amyloid A reveals marginal stability of hexamer Protein Sci. 14 2005 1811 1817
52. L. Wang, H.A. Lashuel, and W. Colon From hexamer to amyloid: marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature Amyloid 12 2005 139 148
53. Y. Wang, S. Srinivasan, Z. Ye, J. Javier Aguilera, M.M. Lopez, and W. Colon Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer Biochem. Biophys. Res. Commun. 407 2011 725 729
54. S. Patke, S. Srinivasan, R. Maheshwari, S.K. Srivastava, J.J. Aguilera, W. Colon, and R.S. Kane Characterization of the oligomerization and aggregation of human serum amyloid A PLoS One 8 2013 e64974
55. S. Inoue, H. Kawano, T. Ishihara, S. Maeda, and S. Ohno Formation of experimental murine AA amyloid fibrils in SAP-deficient mice: high resolution ultrastructural study Amyloid 12 2005 157 163
56. S. Inoue, and R. Kisilevsky In situ electron microscopy of amyloid deposits in tissues Methods Enzymol. 309 1999 496 509
57. T.N. Wien, R. Sorby, L.A. Omtvedt, T. Landsverk, and G. Husby Kinetics of glycosaminoglycan deposition in splenic AA amyloidosis induced in mink Scand. J. Immunol. 60 2004 600 608
58. J.A. Cohlberg, J. Li, V.N. Uversky, and A.L. Fink Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro Biochemistry 41 2002 1502 1511
59. S. Yamamoto, I. Yamaguchi, K. Hasegawa, S. Tsutsumi, Y. Goto, F. Gejyo, and H. Naiki Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH J. Am. Soc. Nephrol. 15 2004 126 133
60. J. McLaurin, T. Franklin, X. Zhang, J. Deng, and P.E. Fraser Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth Eur. J. Biochem. 266 1999 1101 1110
61. M. Egashira, H. Takase, I. Yamamoto, M. Tanaka, and H. Saito Identification of regions responsible for heparin-induced amyloidogenesis of human serum amyloid A using its fragment peptides Arch. Biochem. Biophys. 511 2011 101 106